证券记录 · 已归档季度
CHE
Chemed Corporation · Healthcare · Medical - Care Facilities
17被追踪持有人
0Δ持有人
1.55M持有股份
$954.33M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +0.6% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +2 | 54.82K | $27.24M | +2 | n/a |
| Q2 2026 | 133 | +6 | 8.95M | $4.16B | +9 | −2 |
| Q1 2026 | 129 | 0 | 8.71M | $3.29B | +5 | −6 |
| Q4 2025 | 129 | -2 | 9.90M | $4.23B | +1 | −2 |
| Q3 2025 | 22 | -1 | 5.87M | $2.63B | n/a | −2 |
| Q2 2025 | 21 | +1 | 4.75M | $2.31B | +2 | −1 |
| Q1 2025 | 17 | 0 | 1.55M | $954.33M | +1 | −1 |
| Q4 2024 | 17 | +1 | 1.54M | $817.61M | +2 | −1 |
| Q3 2024 | 15 | 0 | 874.91K | $525.85M | n/a | n/a |
| Q2 2024 | 15 | n/a | 976.21K | $529.86M | n/a | n/a |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 485.10K | +1.0% | $298.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 355.98K | +4.6% | $219.09M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (被动) | 200.75K | +10.9% | $123.53M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 128.68K | +24.9% | $79.18M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 77.06K | -4.5% | $46.81M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 6 | Millennium Management ✦ | 71.87K | -49.0% | $44.22M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 51.10K | +8.5% | $31.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 48.29K | -37.4% | $29.71M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | D. E. Shaw & Co. ✦ | 43.65K | +874.3% | $26.86M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 10 | T. Rowe Price ✦ | 22.82K | -9.8% | $14.04M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 11 | GAMCO Investors ✦ | 19.91K | -6.5% | $12.25M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 14.95K | -6.6% | $9.20M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 11.48K | +43.8% | $7.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 7.67K | -8.2% | $4.72M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 6.80K | 新增 | $4.19M | 0.0% | New | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 3.72K | -29.9% | $2.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 2.01K | -10.2% | $1.24M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $4.19M | 0.0% |
已清仓
| Marshall Wace | $618,276 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 486 持有人, 12.67M 股份, $4.47B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 28
MCNAMARA KEVIN J
Officer, Director · 2.00K 股 · $1.03M
Sep 18
MCNAMARA KEVIN J
Officer, Director · 2.00K 股 · $1.00M
Aug 21
MCNAMARA KEVIN J
Officer, Director · 2.00K 股 · $1.08M
Aug 21
LEE SPENCER S
Officer · 1.00K 股 · $541,040
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 12
SC 13G: AQR CAPITAL MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据